The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely.

But those institutions are now sitting on nearly $1.1 billion combined in reserves ... (Shahrzad Rasekh/CT Mirror) But university officials say that while they can reduce reserves somewhat ...

This is typified by Z alpha-1-antitrypsin (Glu342Lys) that accumulates as polymers within hepatocytes to cause cirrhosis. We have used ion mobility mass spectrometry and electron-capture dissociation ...

The inhaled AAT product could launch in 2030, targeting a $2 billion market for alpha-1 antitrypsin deficiency. Kamada aims to lower costs ... We’re also collecting CT scan data, lung density, and ...

Prime Medicine Inc. has announced its new preclinical program for the treatment of α1-antitrypsin deficiency (AATD). The program is advancing through its final stages of lead optimization, with an IND ...

today unveiled a preclinical program for the treatment of alpha-1 antitrypsin deficiency (AATD), the next program within its liver franchise. Prime Medicine expects to file an investigational new ...

today unveiled a preclinical program for the treatment of alpha-1 antitrypsin deficiency (AATD), the next program within its liver franchise. Prime Medicine expects to file an investigational new drug ...

If you or someone you know is looking for resources and support for problem gambling, call, or chat with the Connecticut Council on Problem Gaming 24/7 confidential Problem Gambling Helpline at 1 ...

Korro Bio, Inc. announced that its investigational drug KRRO-110 has received orphan drug designation from the FDA for treating Alpha-1 Antitrypsin Deficiency (AATD). This designation highlights ...

One name has caught on in the English-speaking West: “Generation Alpha”. It symbolises a fresh chapter, says Mark McCrindle, the Australian demographer behind it. He canvassed people for ideas ...

Korro Bio’s (KRRO) treatment of alpha-1 antitrypsin deficiency received FDA orphan designation, according to a post on the agency’s stie. Published first on TheFly – the ultimate source for ...